Goldman Sachs analyst Bonnie Herzog raised the firm’s price target on Colgate-Palmolive (CL) to $94 from $91 and keeps a Buy rating on the shares. The company reported a strong Q4 with top- and bottom-line beat to end FY25 as higher than expected organic sales growth with broad-based strength flowed through to slightly better than expected gross margins and EBIT margins, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive Navigates Mixed Signals in Earnings Call
- Colgate-Palmolive price target raised to $96 from $88 at Piper Sandler
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
- CL Earnings: Colgate-Palmolive Stock Skyrockets over 5% as Sales Growth Beats Estimates on LATAM Rebound